Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.54 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.54 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.42 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.36 |
| ▸ | ESR1 | P03372 | 1/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.36 |
| ▸ | HTT | P42858 | 2/20 | 0.36 |
| ▸ | MEN1 | O00255 | 2/20 | 0.36 |
| ▸ | NPC1 | O15118 | 1/20 | 0.35 |
| ▸ | POLB | P06746 | 1/20 | 0.35 |
| ▸ | RAB9A | P51151 | 1/20 | 0.35 |
| ▸ | GLA | P06280 | 1/20 | 0.35 |
| ▸ | TSHR | P16473 | 1/20 | 0.35 |
| ▸ | MAPT | P10636 | 2/20 | 0.34 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.34 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.34 |
| ▸ | ATM | Q13315 | 1/20 | 0.34 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.34 |
| ▸ | PKM | P14618 | 1/20 | 0.34 |
| ▸ | GAA | P10253 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Cupferron SCHEMBL1059593 | 0.98 | ALDH1A1 (0.52) | ALDH1A1ALOX15NPSR1HSP90AA1ESR1 | |
| Cupferron SCHEMBL37151 | 0.97 | ALDH1A1 (0.56) | ALDH1A1ALOX15NPSR1HSP90AA1ESR1 | |
| Cupferron SCHEMBL471987 | 0.95 | ALDH1A1 (0.54) | ALDH1A1ALOX15NPSR1HSP90AA1ESR1 | |
| Cupferron SCHEMBL21670426 | 0.95 | ALDH1A1 (0.54) | ALDH1A1ALOX15NPSR1HSP90AA1ESR1 | |
| Cupferron SCHEMBL52291 | 0.95 | ALDH1A1 (0.54) | ALDH1A1ALOX15NPSR1HSP90AA1ESR1 | |
| Cupferron SCHEMBL7506189 | 0.95 | ALDH1A1 (0.54) | ALDH1A1ALOX15NPSR1HSP90AA1ESR1 | |
| Cupferron SCHEMBL94436 | 0.95 | ALDH1A1 (0.54) | ALDH1A1ALOX15NPSR1HSP90AA1ESR1 | |
| Cupferron SCHEMBL21670430 | 0.95 | ALDH1A1 (0.54) | ALDH1A1ALOX15NPSR1HSP90AA1ESR1 | |
| Cupferron SCHEMBL7513315 | 0.95 | ALDH1A1 (0.54) | ALDH1A1ALOX15NPSR1HSP90AA1ESR1 | |
| Cupferron SCHEMBL1719170 | 0.95 | ALDH1A1 (0.54) | ALDH1A1ALOX15NPSR1HSP90AA1ESR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115838187-B | Microwave-assisted organic phase ultra-small ferrite nano-particles and preparation method thereof | 西安超磁纳米生物科技有限公司 | 2024-06-04 | — | — | CN | claimed |
| CN-112299489-B | Ultra-small iron oxide nanoparticles and preparation method and application thereof | 西安超磁纳米生物科技有限公司 | 2022-10-28 | — | — | CN | claimed |
| US-20210308284-A1 | METAL ATOM CLUSTER-EMBEDDED MAGNETIC IRON OXIDE NANOPARTICLE (MION), AND PREPARATION METHOD AND APPLICATION THEREOF | XI'AN SUPERMAG BIO-NANOTECH CO., LTD. (CN) | 2021-10-07 | — | — | US | claimed |
| US-20150225332-A1 | METHOD FOR PRODUCING ALPHA,BETA-UNSATURATED CARBOXYLIC ACID-N,N-DISUBSTITUTED AMIDE AND METHOD FOR PRODUCING 3-ALKOXYCARBOXYLIC ACID-N,N-DISUBSTITUTED AMIDE | IDEMITSU KOSAN CO., LTD. (JP) | 2015-08-13 | — | — | US | claimed |
| US-20140235894-A1 | METHOD FOR PRODUCING ALPHA,BETA-UNSATURATED CARBOXYLIC ACID-N,N-DISUBSTITUTED AMIDE AND METHOD FOR PRODUCING 3-ALKOXYCARBOXYLIC ACID-N,N-DISUBSTITUTED AMIDE | IDEMITSU KOSAN CO., LTD. (JP) | 2014-08-21 | — | — | US | claimed |
| EP-2664611-A1 | Method for producing alpha,beta-unsaturated carboxylic acid-N,N-disubstituted amide and method for producing 3-alkoxycarboxylic acid-N,N-disubstituted amide | Idemitsu Kosan Co., Ltd (JP) | 2013-11-20 | — | — | EP | claimed |
| US-20120088931-A1 | METHOD FOR PRODUCING ALPHA,BETA-UNSATURATED CARBOXYLIC ACID-N,N-DISUBSTITUTED AMIDE AND METHOD FOR PRODUCING 3-ALKOXYCARBOXYLIC ACID-N,N-DISUBSTITUTED AMIDE | IDEMITSU KOSAN CO., LTD. (JP) | 2012-04-12 | — | — | US | claimed |
| CN-115838187-B | Microwave-assisted organic phase ultra-small ferrite nano-particles and preparation method thereof | 西安超磁纳米生物科技有限公司 | 2024-06-04 | — | — | CN | disclosed |
| CN-115520907-A | Ultra-small ferrite nano-particles with active groups, and preparation and application thereof | 西安超磁纳米生物科技有限公司 | 2022-12-27 | — | — | CN | disclosed |
| US-20210308284-A1 | METAL ATOM CLUSTER-EMBEDDED MAGNETIC IRON OXIDE NANOPARTICLE (MION), AND PREPARATION METHOD AND APPLICATION THEREOF | XI'AN SUPERMAG BIO-NANOTECH CO., LTD. (CN) | 2021-10-07 | — | — | US | disclosed |
| WO-2015140160-A1 | MICELLAR NANOPARTICLES CONTAINING ANTITUMORAL GLYCOSIDES | FUNDACIÓN CENTRO NACIONAL DE INVESTIGACIONES CARDIOVASCULARES CARLOS III (ES) | 2015-09-24 | — | — | WO | disclosed |
| EP-2921179-A1 | Micellar nanoparticles containing antitumoral glycosides | Fundación Centro Nacional de Investigaciones Cardiovasculares Carlos III (CNIC) (ES) | 2015-09-23 | — | — | EP | disclosed |
| US-20150225332-A1 | METHOD FOR PRODUCING ALPHA,BETA-UNSATURATED CARBOXYLIC ACID-N,N-DISUBSTITUTED AMIDE AND METHOD FOR PRODUCING 3-ALKOXYCARBOXYLIC ACID-N,N-DISUBSTITUTED AMIDE | IDEMITSU KOSAN CO., LTD. (JP) | 2015-08-13 | — | — | US | disclosed |
| EP-2664611-A1 | Method for producing alpha,beta-unsaturated carboxylic acid-N,N-disubstituted amide and method for producing 3-alkoxycarboxylic acid-N,N-disubstituted amide | Idemitsu Kosan Co., Ltd (JP) | 2013-11-20 | — | — | EP | disclosed |
| US-20120088931-A1 | METHOD FOR PRODUCING ALPHA,BETA-UNSATURATED CARBOXYLIC ACID-N,N-DISUBSTITUTED AMIDE AND METHOD FOR PRODUCING 3-ALKOXYCARBOXYLIC ACID-N,N-DISUBSTITUTED AMIDE | IDEMITSU KOSAN CO., LTD. (JP) | 2012-04-12 | — | — | US | disclosed |
| EP-2426103-A1 | METHOD FOR PRODUCING ALPHA, BETA-UNSATURATED CARBOXYLIC ACID-N,N-DISUBSTITUTED AMIDE AND METHOD FOR PRODUCING 3-ALKOXYCARBOXYLIC ACID-N,N-DISUBSTITUTED AMIDE | Idemitsu Kosan Co., Ltd. (JP) | 2012-03-07 | — | — | EP | disclosed |
| EP-1123915-B1 | Process for producing alpha, beta-unsaturated carboxylic acid esters and catalyst for use in such process | NIPPON CATALYTIC CHEM IND (JP) | 2004-07-28 | — | — | EP | disclosed |
| US-6541656-B2 | Reacting an alpha, beta unsaturated carboxylic acid ester with a heterocyclic oxygen nitrogen, or sulfur compound | NIPPON SHOKUBAI COMPANY, LTD. (JP) | 2003-04-01 | — | — | US | disclosed |
| US-20010034300-A1 | Reacting an alpha, beta unsaturated carboxylic acid ester with a heterocyclic oxygen nitrogen, or sulfur compound | NIPPON SHOKUBAI COMPANY LTD. (JP) | 2001-10-25 | — | — | US | disclosed |
| EP-1123915-A1 | Process for producing alpha, beta-unsaturated carboxylic acid esters and catalyst for use in such process | Nippon Shokubai Co., Ltd. (JP) | 2001-08-16 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150225332-A1 | METHOD FOR PRODUCING ALPHA,BETA-UNSATURATED CARBOXYLIC ACID-N,N-DISUBSTITUTED AMIDE AND METHOD FOR PRODUCING 3-ALKOXYCARBOXYLIC ACID-N,N-DISUBSTITUTED AMIDE | FASN, NAAA, FAAH | ALDH1A1 513/4885ALOX15 70/4885NPSR1 1200/4885 |
| US-20140235894-A1 | METHOD FOR PRODUCING ALPHA,BETA-UNSATURATED CARBOXYLIC ACID-N,N-DISUBSTITUTED AMIDE AND METHOD FOR PRODUCING 3-ALKOXYCARBOXYLIC ACID-N,N-DISUBSTITUTED AMIDE | FASN, NAAA, FAAH | ALDH1A1 513/4885ALOX15 70/4885NPSR1 1200/4885 |
| US-20120088931-A1 | METHOD FOR PRODUCING ALPHA,BETA-UNSATURATED CARBOXYLIC ACID-N,N-DISUBSTITUTED AMIDE AND METHOD FOR PRODUCING 3-ALKOXYCARBOXYLIC ACID-N,N-DISUBSTITUTED AMIDE | FASN, NAAA, FAAH | ALDH1A1 513/4885ALOX15 70/4885NPSR1 1200/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.